{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T09:22:29Z","timestamp":1789982549628,"version":"4.0.1"},"reference-count":25,"publisher":"The Company of Biologists","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,1,1]]},"abstract":"<jats:title>SUMMARY<\/jats:title>\n               <jats:p>Evidence from multiple animal models demonstrates that testosterone plays a crucial role in the progression of symptoms in spinal and bulbar muscular atrophy (SBMA), a condition that results in neurodegeneration and muscle atrophy in affected men. Mice bearing a transgene encoding a human androgen receptor (AR) that contains a stretch of 112 glutamines (expanded polyglutamine tract; AR112Q mice) reproduce several aspects of the human disease. We treated transgenic male AR112Q mice with testosterone for 6 months. Surprisingly, testosterone treatment of AR112Q males did not exacerbate the disease. Although transgenic AR112Q males exhibited functional deficits when compared with non-transgenics, long-term testosterone treatment had no effect on motor function. Testosterone treatment also failed to affect cellular markers of disease, including inclusion formation (the accumulation of large nuclear aggregates of mutant AR protein) and levels of unphosphorylated neurofilament heavy chain. These data suggest that the mechanism of disease in SBMA saturates at close to endogenous hormone levels and that individuals with SBMA who take, or have taken, testosterone for its putative therapeutic properties are unlikely to suffer adverse effects.<\/jats:p>","DOI":"10.1242\/dmm.007849","type":"journal-article","created":{"date-parts":[[2011,9,28]],"date-time":"2011-09-28T06:30:20Z","timestamp":1317191420000},"page":"141-145","source":"Crossref","is-referenced-by-count":11,"title":["Testosterone treatment fails to accelerate disease in a transgenic mouse model of spinal and bulbar muscular atrophy"],"prefix":"10.1242","volume":"5","author":[{"given":"Erica S.","family":"Chevalier-Larsen","sequence":"first","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, Thomas Jefferson University, Philadelphia, PA 19107, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane E.","family":"Merry","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, Thomas Jefferson University, Philadelphia, PA 19107, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"237","reference":[{"key":"2021042500531843800_b1-0050141","doi-asserted-by":"crossref","first-page":"4778","DOI":"10.1523\/JNEUROSCI.0808-04.2004","article-title":"Castration restores function and neurofilament alterations of aged symptomatic males in a transgenic mouse model of spinal and bulbar muscular atrophy","volume":"24","author":"Chevalier-Larsen","year":"2004","journal-title":"J. Neurosci."},{"key":"2021042500531843800_b2-0050141","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/ajmg.1320550125","article-title":"Androgen receptor gene (CAG)n repeat analysis in the differential diagnosis between Kennedy Disease and other motoneuron disorders","volume":"55","author":"Ferlini","year":"1995","journal-title":"Am. J. Med. Genet."},{"key":"2021042500531843800_b3-0050141","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S1474-4422(10)70321-5","article-title":"Efficacy and safety of dutasteride in patients with spinal and bulbar muscular atrophy: a randomised placebo-controlled trial","volume":"10","author":"Fernandez-Rhodes","year":"2011","journal-title":"Lancet Neurol."},{"key":"2021042500531843800_b4-0050141","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/0022-510X(95)00285-A","article-title":"Testosterone therapy and the pathogenesis of Kennedy\u2019s disease (X-linked bulbospinal muscular atrophy)","volume":"135","author":"Goldenberg","year":"1996","journal-title":"J. Neurol. Sci."},{"key":"2021042500531843800_b5-0050141","doi-asserted-by":"crossref","first-page":"13512","DOI":"10.1073\/pnas.96.23.13512","article-title":"Selective serotonin reuptake inhibitors directly alter activity of neurosteroidogenic enzymes","volume":"96","author":"Griffin","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2021042500531843800_b6-0050141","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0896-6273(02)00834-6","article-title":"Testosterone reduction prevents phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy","volume":"35","author":"Katsuno","year":"2002","journal-title":"Neuron"},{"key":"2021042500531843800_b7-0050141","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/nm878","article-title":"Leuprorelin rescues polyglutamine-dependent phenotypes in a transgenic mouse model of spinal and bulbar muscular atrophy","volume":"9","author":"Katsuno","year":"2003","journal-title":"Nat. Med."},{"key":"2021042500531843800_b8-0050141","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1212\/WNL.18.7.671","article-title":"Progressive proximal spinal and bulbar muscular atrophy of late onset: a sex-linked recessive trait","volume":"18","author":"Kennedy","year":"1968","journal-title":"Neurology"},{"key":"2021042500531843800_b9-0050141","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1136\/jnnp.2006.101899","article-title":"Administration of testosterone results in reversible deterioration in Kennedy\u2019s disease","volume":"79","author":"Kinirons","year":"2008","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"2021042500531843800_b10-0050141","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/352077a0","article-title":"Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy","volume":"353","author":"La Spada","year":"1991","journal-title":"Nature"},{"key":"2021042500531843800_b11-0050141","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/ana.410440216","article-title":"Nuclear inclusions of the androgen receptor protein in spinal and bulbar muscular atrophy","volume":"44","author":"Li","year":"1998","journal-title":"Ann. Neurol."},{"key":"2021042500531843800_b12-0050141","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1074\/jbc.M609972200","article-title":"Soluble androgen receptor oligomers underlie pathology in a mouse model of SBMA","volume":"5","author":"Li","year":"2007","journal-title":"J. Biol. Chem."},{"key":"2021042500531843800_b13-0050141","doi-asserted-by":"crossref","first-page":"18259","DOI":"10.1073\/pnas.0705501104","article-title":"Overexpression of wild-type androgen receptor in muscle recapitulates polyglutamine disease","volume":"104","author":"Monks","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2021042500531843800_b14-0050141","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1093\/hmg\/ddp115","article-title":"Cytoplasmic retention of polyglutamine-expanded androgen receptor ameliorates disease via autophagy in a mouse model of spinal and bulbar muscular atrophy","volume":"18","author":"Montie","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"2021042500531843800_b15-0050141","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.neuron.2010.08.034","article-title":"Native functions of the androgen receptor are essential to pathogenesis in a Drosophila model of spinal and bulbar muscular atrophy","volume":"67","author":"Nedelsky","year":"2010","journal-title":"Neuron"},{"key":"2021042500531843800_b16-0050141","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0303-7207(95)03741-1","article-title":"CAG-repeat expansion in androgen receptor in Kennedy\u2019s disease is not a loss of function mutation","volume":"177","author":"Neuschmid-Kaspar","year":"1996","journal-title":"Mol. Cell. Endocrinol."},{"key":"2021042500531843800_b17-0050141","doi-asserted-by":"crossref","first-page":"35567","DOI":"10.1074\/jbc.M110.146845","article-title":"An interdomain interaction of the androgen receptor is required for its aggregation and toxicity in spinal and bulbar muscular atrophy","volume":"285","author":"Orr","year":"2010","journal-title":"J. Biol. Chem."},{"key":"2021042500531843800_b18-0050141","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1046\/j.1365-2826.2003.01074.x","article-title":"Androgen 5-alpha-reductase type 2 is highly expressed and active in rat spinal cord motor neurones","volume":"15","author":"Pozzi","year":"2003","journal-title":"J. Neuroendocrinol."},{"key":"2021042500531843800_b19-0050141","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1212\/WNL.59.5.770","article-title":"Expression of X-linked bulbospinal muscular atrophy (Kennedy disease) in two homozygous women","volume":"59","author":"Schmidt","year":"2002","journal-title":"Neurology"},{"key":"2021042500531843800_b20-0050141","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3109\/07853890008998825","article-title":"Androgens and the control of skeletal muscle protein synthesis","volume":"32","author":"Sheffield-Moore","year":"2000","journal-title":"Ann. Med."},{"key":"2021042500531843800_b21-0050141","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1093\/hmg\/8.5.731","article-title":"Polyglutamine-expanded androgen receptors form aggregates that sequester heat shock proteins, proteasome components and SRC-1, and are suppressed by the HDJ-2 chaperone","volume":"8","author":"Stenoien","year":"1999","journal-title":"Hum. Mol. Genet."},{"key":"2021042500531843800_b22-0050141","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S0896-6273(02)00875-9","article-title":"Androgen-dependent neurodegeneration by polyglutamine-expanded human androgen receptor in Drosophila","volume":"35","author":"Takeyama","year":"2002","journal-title":"Neuron"},{"key":"2021042500531843800_b23-0050141","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.nbd.2008.11.007","article-title":"Androgens inhibit androgen receptor promoter activation in motor neurons","volume":"33","author":"Vismara","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"2021042500531843800_b24-0050141","doi-asserted-by":"crossref","first-page":"50855","DOI":"10.1074\/jbc.M209466200","article-title":"Ligand promotes intranuclear inclusions in a novel cell model of spinal and bulbar muscular atrophy","volume":"277","author":"Walcott","year":"2002","journal-title":"J. Biol. Chem."},{"key":"2021042500531843800_b25-0050141","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1172\/JCI28773.","article-title":"Androgen-dependent pathology demonstrates myopathic contribution to the Kennedy disease phenotyope in a mouse knock-in model","volume":"116","author":"Yu","year":"2006","journal-title":"J. Clin. Invest."}],"container-title":["Disease Models &amp; Mechanisms"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.biologists.com\/dmm\/article-pdf\/5\/1\/141\/1580771\/141.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/journals.biologists.com\/dmm\/article-pdf\/5\/1\/141\/1580771\/141.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,25]],"date-time":"2021-04-25T00:54:00Z","timestamp":1619312040000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.biologists.com\/dmm\/article\/5\/1\/141\/3199\/Testosterone-treatment-fails-to-accelerate-disease"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1,1]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1,1]]}},"URL":"https:\/\/doi.org\/10.1242\/dmm.007849","relation":{},"ISSN":["1754-8411","1754-8403"],"issn-type":[{"value":"1754-8411","type":"electronic"},{"value":"1754-8403","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1,1]]}}}